PMGroup Worldwide and Visions4Health have launched the Excellence in Healthcare Partnerships (EHP) Awards to recognise ...

The NHS has announced the launch of a new initiative aimed at identifying pancreatic cancer in its earliest stages. The three ...

Biocartis Group of Companies (Biocartis) has announced the appointment of Ben Svarczkopf as its new Senior Vice President ...

eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derived ...

Teva’s experimental anti-PD1-IL2 ATTENUKINE therapy is designed to selectively deliver interleukin-2 to PD-1-expressing T ...

A new investigational treatment has shown strong and lasting responses in multiple myeloma patients with extramedullary ...

EDX Medical Group has entered into an agreement with Spire Healthcare Group to advance diagnostic innovations aimed at ...

UCB has announced new three-year data from phase 3 trials and their open-label extensions investigating BIMZELX (bimekizumab) ...

Aravax has announced the appointment of Louise Peacock as its new Chief Regulatory and Quality Officer. Peacock brings over ...

In a move to progress treatment efficacy, oncologists widely agree that, in the future, cancer treatments will become ...

Zusduri, which is delivered directly into the bladder in an out-patient procedure, is now the first and only medication approved by the US regulator to treat adults with recurrent low-grade ...

Argenx has presented positive phase 2 results for efgartigimod in myositis and Sjogren’s disease at EULAR 2025. The company ...